Related Experiment Video
Updated: Feb 20, 2026

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
Expression of protein kinase C gamma promotes cell migration in colon cancer
Catríona M Dowling1,2, Sheri L Hayes1,2, James J Phelan3
1Graduate Entry Medical School, University of Limerick, Limerick, Ireland.
Abstract:
Despite extensive efforts, Protein Kinase Cs (PKCs) have proven to be an intractable target in cancer therapies. Traditionally it was accepted that PKCs act as tumour promoters, however new research suggests that PKCs may play an important role in the suppression of cancer. A challenge in targeting PKCs is the limited data available in patient samples. One of the PKC isozymes, PKC gamma, is thought to be present only in the brain and has been largely neglected in the context of cancer. Analysis of gene expression levels of PKC gamma in patient matched normal and colon cancer tissue samples revealed an up-regulation of the gene in the cancer tissue of 54% of the patients examined. Mechanistically we demonstrate that a reduction in the levels of PKC gamma in the colon cancer cells inhibits cell migration and foci formation. Further to this, we observe an increase in cell adhesion and proliferation following the reduction of PKC gamma levels in the cell. Thus, PKC gamma plays a key role in colon cancer; making it an important isozyme that needs to be reconsidered in the context of cancer therapies.
Insights
Protein Kinase C gamma (PKC gamma) is upregulated in colon cancer, contrary to traditional views. Reducing PKC gamma inhibits cancer cell migration and growth, suggesting its potential as a novel cancer therapy target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Protein Kinase Cs (PKCs) are implicated in cancer, traditionally viewed as tumor promoters.
- Emerging evidence suggests PKCs may also function in tumor suppression.
- Limited patient sample data complicates targeting PKCs in cancer therapy.
Purpose of the Study:
- To investigate the role of PKC gamma, a largely neglected PKC isozyme, in colon cancer.
- To analyze PKC gamma expression in patient-matched normal and colon cancer tissues.
- To elucidate the functional impact of PKC gamma on colon cancer cell behavior.
Main Methods:
- Gene expression analysis of PKC gamma in 54% of patient colon cancer tissues compared to normal tissues.
- Functional assays in colon cancer cells to assess the effects of reduced PKC gamma levels on cell migration, foci formation, adhesion, and proliferation.
Main Results:
- PKC gamma gene expression was significantly upregulated in 54% of colon cancer tissues.
- Reduced PKC gamma levels in colon cancer cells inhibited cell migration and foci formation.
- Decreased PKC gamma expression led to increased cell adhesion and proliferation.
Conclusions:
- PKC gamma plays a critical role in colon cancer progression.
- PKC gamma represents a potential therapeutic target for colon cancer treatment.
- Reconsideration of PKC gamma's role in cancer is warranted for developing new therapies.
Related Concept Videos
MAPK Signaling Cascades
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

